"the best thing about the scenario you laid out is if they can get it approved overseas, sure will increase the chances of the fda approving it here"
In my quest for accuracy I must point out that the above statement is not accurate. The chances are not increased of getting FDA approval based on EMA approval. The FDA is many times more strict on their policy than the EMA. However, a U.S. Phase II Clinical trial approval does increase the odds for the EMA to approve a drug for use in Europe.
Agree. Wish I would have ran across this when it was trading below $2. I believe the share price will explode this month after the release of phase II. looking forward to earning an annual salary in one months time.